Security key
09077B104
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)
CUSIP: 09077B104
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stocks, par value $0,0001 per share
- Total 13F shares
- 13,178,637
- Total 13F value
- $7,494,979
- Share change
- -103,395
- SEC-reported price per share
- $0.57
- Number of holders
- 40
- Value change
- -$262,374
- Number of buys
- 20
- Number of sells
- 13
- Shares outstanding
- 58,548,563
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
40
Top holders
10
BCAB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
BioAtla, Inc. SEC filings
BioAtla, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09077B104
Recent filing periods:
Ownership snapshot
Top reported holders of BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ACORN BIOVENTURES, L.P.
Disclosed value leader
ACORN CAPITAL ADVISORS, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
3/4/5
Lead comparable stake: 8.3%
13D/G row: ACORN BIOVENTURES, L.P.
Showing 1-6 of 15 holder rows.
Quick read
ACORN BIOVENTURES, L.P. leads the comparable SEC ownership view at 8.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ACORN BIOVENTURES, L.P.'s linked filing trail.
Comparable ownership
Top 5
ACORN BIOVENTURES, L.P.
8.3%
HIGHBRIDGE CAPITAL MANAGEMENT LLC
7.7%
Jay M. Short PhD
6.6%
OPOKA INVESTMENT FUND Co
4.8%
MILLENNIUM MANAGEMENT LLC
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. |
13D/G
Anders Hove
|
8.3%
|
$2,127,449
4,835,111 shares
|
$0 | 15 May 2025 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
7.7%
|
$2,129,415
4,839,579 shares
|
-$1,104,235 | 31 Mar 2025 |
| Jay M. Short PhD |
13D/G
Jay M. Short
|
6.6%
|
$1,700,884
3,865,646 shares
|
$0 | 31 Dec 2024 |
| OPOKA INVESTMENT FUND Co |
13D/G
|
4.8%
|
$1,933,227
2,810,331 shares
|
-$507,296 | 09 Jul 2025 |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
Company
|
1.9%
|
$482,067
1,095,606 shares
|
$0 | 31 Dec 2024 |
| Scott Andrew Smith |
3/4/5
Director
|
0.55%
|
$125,404
321,550 shares
|
— | 18 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
40
Shares
13,178,637
Rows available
40
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
43
Q4 2025 holders
40
Holder diff
-3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend